MasterControl Raises $150 Million in Series A

by Kay Aloha Villamor in December 16th, 2022

MasterControl, a Salt Lake City, UT-based provider of quality and manufacturing software solutions for the life sciences, announced today the first-ever funding, $150 million Series A.

The round was led by Sixth Street Growth. MasterControl has grown profitably for nearly 30 years, and with this funding, it is valued at $1.3 billion.

MasterControl will use the financing to continue to build and enhance its solutions while also placing more focus on technology that will predict and prevent quality events, and enable true AI-assisted manufacturing optimization.

The proceeds will be used to accelerate the development of SaaS solutions serving the company’s global life sciences customers, which include Pfizer, Cochlear, Thermo Fisher Scientific, and more than 1,100 others worldwide.

“For nearly three decades, we’ve been laser-focused on our mission to make life-changing products available to more people sooner. This commitment has led us to attack inefficiencies in quality and manufacturing that were extending product research and delivery cycles. We see an urgent need to help our customers to deliver their breakthrough technologies to the market faster and at a lower cost,” said Jon Beckstrand, CEO of MasterControl. “Our goal is to add a strategic partner with resources and expertise to help us to meet the significant need for our solutions. We’re fortunate to have the experienced investment team at Sixth Street Growth to help make that a reality.”

Before taking on funding, MasterControl bootstrapped its way to more than $100M in ARR with over 25% YoY growth to date. Well into its expansion to disrupt the $17B manufacturing execution system (MES) market through the launch of Manufacturing Excellence in 2019, it has attracted well over 100 new customers in the MES market and seen more than 100% growth in sales every year.

With half of the top 50 pharma and med device companies as customers, MasterControl is poised to enter new markets adjacent to its core pharmaceutical and medical device segments, such as contract development and manufacturing, personalized medicine, and cell and gene therapy.

Company: MasterControl, Inc.

Raised: $150.0M

Round: Series A

Funding Month: December 2022

Lead Investors: Sixth Street Growth

Additional Investors:

Company Website:

Software Category: Quality and Manufacturing Software for Life Sciences

About the Company: MasterControl is a leading cloud-based quality and manufacturing software provider for life sciences and other regulated industries. For three decades, Its mission has been the same as that of its customers – to bring life-changing products to more people sooner. MasterControl helps organizations digitize, automate, and connect quality and manufacturing processes. Innovative MasterControl tools have a proven track record of improving product quality, reducing cost, and accelerating time to market. Over 1,100 companies worldwide use MasterControl solutions to streamline operations, maintain compliance, easily analyze and interpret large amounts of data, and visualize business insights in real-time. 


Your cart